CLOs on the Move

Bristol-Myers Squibb

www.bms.com

 
Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious and life-threatening diseases. Our medicines are helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience, fibrosis and others. Through the Bristol-Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions, giving new hope to some of the world`s most vulnerable people. Each day, our employees around the world work together for patients – it drives everything we do.
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.bms.com
  • 345 Park Avenue
    New York, NY USA 10154
  • Phone: 212.546.4000

Executives

Name Title Contact Details
Terra Buckley
Chief Compliance and Ethics Officer Profile
Felecia Ettenberg
Senior Vice President and Deputy General Counsel, Pipeline to Patient Global Law Profile
Julia Weisberg
Assistant General Counsel, Global Profile
Joy Seymour
Senior Director of Global Regulatory Affairs Profile
Michael Haughney
Director, Global Compliance Monitoring and Analytics Profile

Jobs

Head of Global Talent Acquisition

Bristol-Myers Squibb Princeton, NJ
Job Description

The Head Global Talent Acquisition will report to the Head of Global Talent and Organizational Effectiveness who reports to the company’s Chief Human Resources Officer. The incumbent will lead a global team of 30+ BMS individuals and 110+ recruitment professionals working for Cielo (US) and Alexander Mann ...

Similar Companies

Evolve Biosystems

Evolve BioSystems is a spin-out from the Foods For Health Institute (FFHI) at the University of California, Davis. The company builds on more than a decade of research into the infant gut microbiome and its unique interaction with breast milk components, established by the founding scientists including Bruce German, David Mills, Carlito Lebrilla, Daniela Barile and Samara Freeman. Their fundamental research and translational clinical trials have been enabled by more than $15 million in federal and private grants since 2004. Under the leadership of CEO Dr. David Kyle, Evolve completed a $1 million seed funding round in mid-2014, a $9 million Series A round in August 2015 and most recently a $20 million Series B capital raise in 2017. Evolve has now successfully completed a milestone proof-of-concept study to demonstrate the efficacy of its initial proprietary offering, with a series of upcoming trials scheduled across both human and animal health applications. With a strong portfolio of intellectual property developed at UC Davis, a world-class management team plus blue-chip investors, and an unwavering dedication to allowing science to direct our product development, Evolve continues to expand it`s pipeline of next generation microbiome-based solutions to establish, restore, and maintain a healthy gut microbiome.

Lybradyn Inc

Lybradyn Inc is a Oak Brook, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

G-Biosciences/ Genotech

G-Biosciences/ Genotech is a Maryland Heights, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NitroMed, Inc.

NitroMed, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

TissueTech

TissueTech, Inc is a Biotechnology company headquartered in Miami, FL. TissueTech, Inc. is a leader in regenerative amniotic tissue-based products for use in the ophthalmology, optometry, musculoskeletal and wound care markets. TissueTech offers its portfolio of amniotic membrane and umbilical cord-based tissue and device products through its commercial entities: BioTissue, Inc: the industry leader in regenerative tissue therapies for ocular surface diseases and disorders. Amniox Medical: a leading technology provider to the musculoskeletal and wound care markets.